A study combining the detection of ctDNA KRAS mutations with CA 19-9 levels differentiated PDAC (47 patients) from chronic pancreatitis (31 patients) with a sensitivity of up to 98% and a specificity of 77% [55]. This evidence concerns the gene KRAS and chronic pancreatitis.